MIST
Milestone Pharmaceuticals Inc.
+0.03 (+3.27%)0.92USD643K成交股數114M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 559K | 238K | – | – | 0 | 0 | – | – | – | – | – | – |
| 營業成本 | 32K | 14K | – | – | 0 | 0 | – | – | – | – | – | – |
| 毛利 | 527K | 224K | – | – | 0 | 0 | – | – | – | – | – | – |
| 毛利率 | 94.3% | 94.1% | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.5M | 3.3M | 5.5M | 3.9M | 3.7M | 5.0M | 4.0M | 2.8M | 3.6M | 5.5M | 6.7M | 8.6M |
| 銷售管理費用 | 22.6M | 4.8M | −18K | 3.3M | 8.9M | 5.2M | 3.7M | 5.0M | 4.0M | 3.4M | 4.2M | 4.4M |
| 營業利益 | −25.6M+105% | −23.7M+15% | −17.3M+79% | −11.8M+22% | −12.5M+20% | −20.5M+49% | −9.6M-37% | −9.7M-41% | −10.5M | −13.8M | −15.4M | −16.4M |
| 營業利益率 | -4,585.0% | -9,942.4% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −28.6M+121% | −26.1M+26% | 45.6M-583% | −11.9M+27% | −13.0M+25% | −20.8M-145% | −9.4M-37% | −9.4M-42% | −10.4M | 46.0M | −15.1M | −16.0M |
| 淨利率 | -5,118.8% | -10,952.1% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.21+5% | -0.20-35% | -0.12-14% | -0.12-14% | -0.20-5% | -0.31-3% | -0.14-60% | -0.14-62% | -0.21 | -0.32 | -0.35 | -0.37 |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 170M | 71.3M | 73.0M | 46.7M | 42.5M | 45.1M | 12.8M | 13.3M | 10.1M | 13.8M | 9.9M | 32.6M |
| 應收帳款 | 2.7M | 1.6M | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 4.7M | 1.8M | 648K | – | – | – | – | – | – | – | – | – |
| 總資產 | 182M | 194M | 114M | 87.8M | 47.4M | 61.9M | 82.7M | 89.2M | 96.0M | 75.2M | 87.1M | 97.0M |
| 有息負債 | 59.2M | 58.2M | 57.2M | 56.2M | 55.2M | 54.3M | 52.4M | 51.5M | 50.6M | 49.8M | 48.9M | 48.1M |
| 總負債 | 163M | 158M | 71.8M | 67.2M | 65.2M | 68.0M | 58.7M | 57.3M | 56.1M | 58.5M | 58.6M | 56.6M |
| 股東權益 | 18.2M | 36.0M | 41.8M | 20.5M | −17.7M | −6.1M | 24.0M | 32.0M | 39.9M | 16.8M | 28.5M | 40.4M |
| 負債比 | 90.0% | 81.4% | 63.2% | 76.6% | 137.4% | 109.9% | 71.0% | 64.2% | 58.4% | 77.7% | 67.3% | 58.4% |
| 淨現金(現金 − 有息負債) | 111M | 13.1M | 15.9M | −9.5M | −12.7M | −9.2M | −39.6M | −38.3M | −40.5M | −36.0M | −39.0M | −15.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.1M+15% | – | – | – | −14.0M | – | – | −8.9M | – | – | – |
| 資本支出 | – | 45K | – | – | – | 6K | – | – | – | – | – | – |
| 自由現金流 | – | −16.1M+15% | – | – | – | −14.0M | – | – | – | – | – | – |
| 折舊攤銷 | – | 56K | – | – | – | 27K | – | – | 28K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -6,763.9% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −63K | –% | -0.75 | −49.3M |
| FY2024 | – | – | −42K | –% | -0.67 | −28.9M |
| FY2023 | – | – | −60K | –% | -1.39 | −46.5M |
| FY2022 | – | – | −58.4M | –% | -1.38 | −52.7M |
| FY2021 | – | – | −42.9M | –% | -1.02 | – |
| FY2020 | – | – | −50.0M | –% | -1.70 | – |
| FY2019 | – | – | −55.2M | –% | -3.50 | −51.6M |
| FY2018 | – | – | −23.2M | –% | 72.63 | −21.1M |